Adipotide is an experimental peptide built to target fat tissue and trigger cell death there, with a cell-killing part made of D-amino acids. It is not approved and is banned in sport as an unapproved substance, and its few studies are in animals. PepBank shows 5 results on Adipotide from animal and lab studies. No study in people has reported results yet. Data as of 2026-10-30.
Also known as FTPP, TP01, Prohibitin-TP01, Prohibitin targeting peptide 1
| What it is | Conjugate, 25 amino acids |
|---|---|
| Approval | Not approved for any use |
| In sport | Banned in sport (WADA S0) |
| Studies | 1 study with results. It gave Adipotide, with 5 results. 5 in animals |
| Clinical trials | 1 registered: 0 active or planned, 0 with posted results |
| Community use | Wiki-reported weight loss use. Direct reports remain unverified. |
Fat-targeted proapoptotic peptide conjugate with a D-amino-acid cell-killing segment.
Amino acids in one chain
The oldest paper on Adipotide in PepBank is from 2011.
A registered trial of Adipotide started (NCT01262664).
The key facts about the molecule. Long codes are in the closed section below.
Three-letter sequenceCys-Lys-Gly-Gly-Arg-Ala-Lys-Asp-Cys-Gly-Gly-D(Lys-Leu-Ala-Lys-Leu-Ala-Lys)2
Results grouped by what the studies measured. Each card shows where its results come from.
In monkeys, imaging showed less white fat after adipotide treatment. Science translational medicine, 2011
In monkeys, adipotide improved insulin resistance. Science translational medicine, 2011
In monkeys, adipotide changed kidney tubule function, and the changes were reversible. Science translational medicine, 2011
Studies in people come first, then studies in animals and in the lab.
ClinicalTrials.gov lists 1 trial of Adipotide. 0 are active or planned, and 0 have posted results. PepBank does not show trial results.
Solid bars are dates that happened. Hatched bars are planned dates. Data from ClinicalTrials.gov.
No approved medicine contains it.
No approved medicine contains it.
On the 2026 Prohibited List, section S0.
No. Not approved for any use. Its most advanced trial is in phase 1. The FDA, the EMA and the other sources we use show no approval (as of 13 Oct 2026). Banned in sport (WADA S0).
Laws and labels change, so check the regulator for the current status.
PepBank has 1 safety result from studies of Adipotide. None of them come from studies in people, so they do not show what happens in people.
What people report online. It comes from forums and guides, not from studies.
An automated community wiki reports this protocol. Specific community reports were not identified. The protocol does not establish safety or efficacy.
| Context | Route | Amount | How often | How long | Agreement | Sources |
|---|---|---|---|---|---|---|
| Wiki-reported weight loss protocol. Direct community reports remain unverified. | subcutaneous injection | 0.5 to 1 mg per dose | once daily | 2 to 4 weeks | Single automated wiki source. No independent community report identified. | S1 |
Gaps
Specific community reports, actual use and product identity remain unverified. Vendor links alone do not establish seller status or affiliate payments.
The answer links to every study it uses.
AI wrote and checked these results. AI can make mistakes, so check important results against the source.
PepBank is a research reference. Talk to a doctor before you use any peptide.
Ask your AI about Adipotide
Curo is a peptide shop. PepBank and Curo have the same owner. See the Curo catalog (opens in a new tab).
In PepBank now:147 peptides, 6 blends and 13 other compounds97,577 study results from 17,383 studies8,473 clinical trialsUpdated